Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

The merger comes as the acetaminophen drug faces scrutiny from the Trump administration and a lawsuit from Texas.

The combined company will have a large stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and ...

Attorney General Ken Paxton files an acetaminophen lawsuit in Texas, aligning with Trump and RFK Jr. on autism. It’s political, designed to win an endorsement.

Kenvue faces investor pressure amid strategic review, leadership changes and litigation risk Trump administration position on Tylenol erased $10 billion in market value Potential sale or spin-off of ...

Doctors say misinformation is spreading about Tylenol online. Since President Donald Trump announced at a White House news conference three weeks ago that pregnant women's use of Tylenol might raise ...

Health Secretary Robert F. Kennedy, Jr. Thursday reasserted the unproven link between the pain reliever Tylenol and autism, and suggested people who opposed the theory were motivated by hatred for ...